Methods for treating cancers using oral formulations of cytidine analogs
US9125884B2 · kind B2 · utility
2Cited by
6References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2012 |
| Grant date | Sep 8, 2015 |
| Priority date | — |
| Expiry date | Oct 31, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7064
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for treating subjects having a cancer, such as a relapsed or refractory solid tumor, wherein the method comprises administering to the subject a cytidine analog. In certain of the methods, the cytidine analog is administered alone or in combination with one or more anti-cancer agents. Also provided are methods for using a cytidine analog, to treat diseases and disorders including disorders related to abnormal cell proliferation, hematologic disorders, and immune disorders, among others. In certain of the methods, the cytidine analog is formulated in an oral dosage form and administered orally.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.